Thoracic radiotherapy in limited-stage small cell lung cancer / 国际肿瘤学杂志
Journal of International Oncology
;
(12): 296-299, 2010.
Article
in Chinese
| WPRIM
| ID: wpr-388569
ABSTRACT
The effective therapy of limited stage-small cell lung cancer( LS-SCLC) is combined chemotherapy and thoracic radiotherapy(TRT). Early thoracic irradiation is better than later one. Start of any treatment and end of radiotherapy less than 30 days is associated with improved survival in LS-SCLC patients. Concurrent chemoradiotherapy results in longer survival time than sequential and alternating chemoradiotherapy. There are no clear answers on optimal irradiation dose. Hyperfractinated irradiation may have therapeutic benefit compared with conventional irradiation.
Full text:
Available
Index:
WPRIM (Western Pacific)
Language:
Chinese
Journal:
Journal of International Oncology
Year:
2010
Type:
Article
Similar
MEDLINE
...
LILACS
LIS